B. M. Tuzuner Et Al. , "CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility," IN VIVO , vol.24, no.1, pp.71-74, 2010
Tuzuner, B. M. Et Al. 2010. CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility. IN VIVO , vol.24, no.1 , 71-74.
Tuzuner, B. M., Ozturk, T., Kisakesen, H. I., Ilvan, S., Zerrin, C., Ozturk, O., ... Isbir, T.(2010). CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility. IN VIVO , vol.24, no.1, 71-74.
Tuzuner, Bora Et Al. "CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility," IN VIVO , vol.24, no.1, 71-74, 2010
Tuzuner, Bora M. Et Al. "CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility." IN VIVO , vol.24, no.1, pp.71-74, 2010
Tuzuner, B. M. Et Al. (2010) . "CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility." IN VIVO , vol.24, no.1, pp.71-74.
@article{article, author={Bora M. Tuzuner Et Al. }, title={CYP17 (T-34C) and CYP19 (Trp39Arg) Polymorphisms and their Cooperative Effects on Breast Cancer Susceptibility}, journal={IN VIVO}, year=2010, pages={71-74} }